Stoke Therapeutics Inc.

NASDAQ: STOK · Real-Time Price · USD
18.16
0.99 (5.77%)
At close: Aug 15, 2025, 3:59 PM
18.22
0.30%
After-hours: Aug 15, 2025, 04:59 PM EDT

Stoke Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-6.69 -2.21 -3.55 -10.27
PEG Ratio
0.22 0.26 -0.32 -0.21
PS Ratio
16.30 26.36 28.94 n/a
PB Ratio
2.60 1.45 1.94 4.05
P/FCF Ratio
-6.84 -2.8 -10.02 -12.94
P/OCF Ratio
-6.86 -2.85 -11.27 -13.17
OCF/S Ratio
-2.38 -9.23 -2.57 n/a
Debt / Equity Ratio
0.01 0.01 0.01 0.01
Quick Ratio
5.81 6.99 7.43 13.37
Current Ratio
5.81 6.99 7.77 13.37
Asset Turnover
0.13 0.04 0.05 n/a
Interest Coverage
n/a n/a n/a -717.21
Return on Equity
-0.39 -0.66 -0.55 -0.39
Return on Assets
-0.33 -0.46 -0.39 -0.36
Return on Invested Capital
-0.43 -0.57 -0.42 -0.38
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
1.00 1.00 1.00 n/a
Net Profit Margin
-2.43 -11.92 -8.15 n/a
Pretax Profit Margin
-2.43 -11.92 -8.15 n/a
Operating Profit Margin
-2.77 -13.07 -8.41 n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-2.71 -12.79 -8.29 n/a